FORME FRUSTE KERATOCONUS (FFK)
Clinical trials for FORME FRUSTE KERATOCONUS (FFK) explained in plain language.
Never miss a new study
Get alerted when new FORME FRUSTE KERATOCONUS (FFK) trials appear
Sign up with your email to follow new studies for FORME FRUSTE KERATOCONUS (FFK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter light therapy may be just as good for treating bulging corneas
Disease control Recruiting nowThis phase 3 trial tests whether a shorter 18-minute ultraviolet (UVA) light exposure works as well as the standard 24-minute exposure during corneal crosslinking for keratoconus and similar conditions. The treatment uses riboflavin (vitamin B2) eye drops followed by UVA light to…
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for down syndrome vision loss: light therapy trial launches
Disease control Recruiting nowThis Phase 3 trial tests a treatment called corneal crosslinking (CXL) for people with Down syndrome who have keratoconus, a condition where the cornea thins and bulges, blurring vision. The procedure uses vitamin B2 eye drops and ultraviolet light to strengthen the cornea. Resea…
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC